Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03801382 · ClinicalTrials.gov registry record · NA
Psychometric Properties of IntelliSpace Cognition
A NA study, sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization.
- Completed
- Registry status
- NA
- Development phase
- 450
- Enrollment target
NCT03801382 is a NA study that has completed, run by Philips Electronics Nederland B.V. acting through Philips CTO organization. The registered enrollment target is 450 participants.
The verdict
NCT03801382, a NA study, has completed, sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization.
- COMPLETED
- Registry status
- NA
- Development phase
- 450 participants
- Enrollment target
Study Summary
This study aims to validate the tests that are on the IntelliSpace Cognition platform and to establish normative data for these tests.
Interventions
- DEVICE IntelliSpace Cognition (ISC)
- DIAGNOSTIC_TEST Paper-Pencil Tests
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2019-08-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03801382
The ClinicalTrials.gov registry entry for NCT03801382 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Electronics Nederland B.V. acting through Philips CTO organization, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which IntelliSpace Cognition (ISC) is the first listed.
NCT03801382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03801382 about?
NCT03801382 is a clinical study titled "Psychometric Properties of IntelliSpace Cognition". This study aims to validate the tests that are on the IntelliSpace Cognition platform and to establish normative data for these tests.
What is the current status of trial NCT03801382?
This trial is currently completed. It is a NA study. The enrollment target is 450 participants. The study started on 2019-04-15. Estimated completion is 2019-08-26.
What interventions are being tested in trial NCT03801382?
The interventions under investigation include: IntelliSpace Cognition (ISC) (DEVICE), Paper-Pencil Tests (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03801382?
This trial is sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.